Congratulations! Dahuanong has obtained the production approval number for the Infectious Bursal Disease (Gumboro Disease) Live Vaccine (Gt Strain), with the veterinary drug production number 190032122, and the product name: Fabiwei.

Recently, Dahuanong has received another significant piece of good news: the Infectious Bursal Disease Live Vaccine (Gt Strain) has been granted a production approval number, with the veterinary drug production number 190032122, and the commercial name: Fabiwei.

Infectious Bursal Disease (IBD), also known as Gumboro Disease or Infectious Bursal Cystitis, is an acute, highly contagious, and immunosuppressive disease in poultry caused by a birnavirus from the family Birnaviridae. It is classified as a Class II animal disease in China. The disease generally has a high incidence rate (up to 100%) and can occur throughout the year without obvious seasonality, with chickens aged 3 to 6 weeks being the most susceptible.

The Infectious Bursal Disease Live Vaccine (Gt Strain) is successfully developed by the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences (hereinafter referred to as "HVRI") through the isolation and identification of a highly virulent strain of Infectious Bursal Disease Virus (IBDV) - the Gx strain, and by domesticating the virus in vitro to obtain a significantly weakened strain adapted to cells with reduced pathogenicity, the Gt strain, which is a safe and effective vaccine with a high rate of immune protection for chickens (Gt strain). Dahuanong has been cooperating with HVRI on the Bursal Project since 2015, and after nearly a decade of development, it has launched this Infectious Bursal Disease Live Vaccine (Gt Strain), which has four major advantages:

1. High safety, with no damage to the bursa of Fabricius;

2. The immune protection effect is good, providing protection against variant strains and highly virulent viruses;

3. Antibodies are produced quickly, at high levels, and have long-lasting duration;

4. The virulence is stable and does not revert to a stronger form. This vaccine has a wide range of applications and can be used for various age groups of breeder flocks, broiler flocks, and layer flocks.

Dahuanong has always taken on the mission of "being an expert in animal health care and serving human health," committing to the development, production, and promotion of ecological, green, and environmentally friendly animal health products. The acquisition of this production approval number not only adds to the company's vaccine business market but also helps a wide range of farmers better prevent and control diseases, ensuring the healthy development of the industry.

Writing / Ouxilan